Lipella Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)9holders
1famous investor
$0.68avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Lipella Pharmaceuticals Inc. in their 13F filings. The largest holders were Sabby Management, LLC ($171K), Geode Capital Management, LLC ($29K) and Vanguard Group Inc. ($24K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lipella Pharmaceuticals Inc.
- CUSIP
- 53630L100
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $22K |
| Exits | 1 | $776 |
Ownership 9 holders
| Sabby Management, LLC | 1.23% | Reduce -7.4% | 249,899 | $171K |
| Geode Capital Management, LLC | 0.00% | No change | 42,090 | $29K |
| Vanguard Group Inc. | 0.00% | No change | 34,520 | $24K |
| Citadel Advisors | 0.00% | New | 22,073 | $15K |
| Two Sigma Investments, LP | 0.00% | Reduce -17.6% | 13,077 | $9K |
| HRT Financial LP | 0.00% | New | 10,333 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +11.4% | 7,708 | $5K |
| FMR LLC | 0.00% | New | 65 | $45 |
| Wells Fargo & Company | 0.00% | Add +3.5% | 30 | $21 |
"% of holder's portfolio" is LIPELLA PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Lipella Pharmaceuticals Inc. the manager owns.